48746 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices 

Director who reports to the Assistant 

Secretary for Health. 

2. OCCHE shall work with the 

Immediate Office of the Secretary, Staff 

Divisions, and Operating Divisions to 

focus on: 

—Identifying communities with 

disproportionate exposures to climate 

hazards and vulnerable populations. 

—Addressing health disparities 

exacerbated by climate impacts to 

enhance community health resilience. 

—Promoting and translating research on 

public health benefits of multisectoral climate actions. 

—Supporting regulatory efforts to 

reduce greenhouse gas emissions and 

criteria air pollution throughout the 

health care sector, including 

participating suppliers and providers. 

—Fostering innovation in climate 

adaptation and resilience for people 

and communities experiencing a 

disproportionate share of climate 

impacts and health inequities. 

—Providing expertise and coordination 

to the White House and other Federal 

agencies related to climate change and 

health equity deliverables and 

activities, including executive order 

implementation, and reporting on 

health adaptation actions under the 

United Nations Framework 

Convention on Climate Change. 

—Promoting training opportunities to 

build the climate and health 

workforce and empower 

communities. 

—Exploring opportunities to partner 

with the philanthropic and private 

sectors to support innovative 

programming to address disparities 

and health sector transformation. 

Delegations of Authority 

Directives or orders made by the 

Secretary or the Assistant Secretary for 

Health, including all delegations and redelegations of authority made to 

officials and employees of affected 

organizational components will 

continue in force pending further 

delegation, if allowed, provided they are 

consistent with this realignment. 

Andrea Palm, 

Deputy Secretary. 

[FR Doc. 2021–18794 Filed 8–30–21; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Center for 

Advancing Translational Sciences 

Advisory Council. 

The meeting will be open to the 

public as indicated below. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov). Individuals who 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: September 23–24, 2021. 

Closed: September 23, 2021, 10:30 a.m. to 

12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Open: September 23, 2021, 1:00 p.m. to 

5:00 p.m. 

Agenda: Report from the Institute Director 

and other staff. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Open: September 24, 2021, 1:00 p.m. to 

5:00 p.m. 

Agenda: To view and discuss Clearance of 

Concepts. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, 6701 

Democracy Boulevard, Room 987/989, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, One 

Democracy Plaza, Room 1072, Bethesda, MD 

20892, 301–435–0809, anna.ramseyewing@

nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: August 25, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18727 Filed 8–30–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Evaluation of 

Office of Acquisitions System (OASYS) 

and FFRDC Contract Administration 

System (FCAS) Vendor Portals 

National Cancer Institute (NCI) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Marla Jacobson, 9609 Medical Center 

Drive, MSC 9742, Rockville, MD 20850 

or call non-toll-free number 240–276– 


khammond on DSKJM1Z7X2PROD with NOTICES